• ‘Good progress' being made in RSV prevention research

    5 days ago - By Healio

    After decades of inactivity following a deadly vaccine failure in the 1960s, “there's been good progress” lately in research to prevent respiratory syncytial virus, according to a speaker at the Infectious Diseases in Children Symposium.
    Mary T. Caserta, MD, a professor of pediatrics at the University of Rochester Medical Center, provided an update on several RSV investigational products and vaccines in development for infants and pregnant mothers during a virtual presentation.
    Caserta noted that a randomized controlled trial of the investigational monoclonal nirsevimab for
    Read more ...